Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate 72516-0013
Product NDC
72516-0013- Manufacturer
- Oryza Pharmaceuticals Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- October 19, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA210293
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 3.75 mg/1 |
| Amphetamine Sulfate | 3.75 mg/1 |
| Dextroamphetamine Saccharate | 3.75 mg/1 |
| Dextroamphetamine Sulfate | 3.75 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Packaging Options(1)
100 TABLET in 1 BOTTLE (72516-013-01)